Abstract:
조류 인플루엔자 바이러스의 HA 단백질 유래의 HA2 절편의 154번째 아미노산인 아스파라긴(N)에 N-글리칸 생성이 일어나지 않도록 154번째 아미노산인 아스파라긴 또는 156번째 아미노산인 세린(S)이나 트레오닌(T)을 다른 아미노산으로 치환하여 HA2 공통 에피톱에 대한 면역원성을 증가시키는 방법과 이러한 방법을 통해 면역원성이 증가된 재조합 바이러스가 제공된다. 본 발명의 HA2 공통 에피톱 면역원성 향상기술과 HA2 공통 에피톱 고면역원성 바이러스는 인플루엔자 예방을 위한 백신주 개발과 백신주로써 유용하게 이용될 수 있다.
Abstract:
A diagnostic strip for a H5 type highly pathogenic avian influenza and general avian influenza is provided to conveniently and rapidly diagnose whether a bird is infected by the H5 type highly pathogenic avian influenza and general avian influenza or not from stool in situ without special testing equipment. The diagnostic strip is characterized in that a monoclonal antibody common to general avian influenza virus in which hemaglutinin antigens are H1 to H15 and a monoclonal antibody specific to a highly pathogenic avian influenza in which a hemaglutinin antigen is H5 are used for diagnosing the highly pathogenic and the general avian influenza in which the hemaglutinin antigen is H5 from stool or tissue of chicken. The method for preparing the diagnostic strip comprises the steps of: (a) respectively absorbing the monoclonal antibody specific to the highly pathogenic avian influenza virus in which the hemaglutinin antigen is H5 and the monoclonal antibody common to general avian influenza virus into a membrane; (b) respectively attaching the antibody absorbed membrane obtained from the step(a) to gold particles so as to prepare an antibody-gold conjugate and then mixing it; and (c) precipitating the conjugate obtained from the step(b) in a basic material and then drying it.
Abstract:
A virus strain for preparing a vaccine is provided to have excellent defending effect on low pathogenic avian influenza H9N2 virus strain. And a vaccine is provided to be able to effectively prevent diseases caused by the low pathogenic avian influenza H9N2 recording the high mortality of bird. The low pathogenic avian influenza H9N2 virus strain for preparing vaccine is characterized in that a motif of hemangioblast protein cleavage site amino acid sequence has TSGR and it shows the defending capacity against domestic low pathogenic avian influenza virus. The method for preparing a vaccine for the low pathogenic avian influenza H9N2 virus strain comprises the steps of: (a) inactivating the low pathogenic avian influenza H9N2 virus strain; and (b) mixing the inactivated virus with an adequate excipient.
Abstract:
A recombinant protein of avian influenza virus and a diagnostic composition of avian influenza containing the same protein are provided to mass produce the antigen for diagnosis of avian influenza cheaply, so that the disease caused by avian influenza is prevented. The method for producing the recombinant nucleus protein of avian influenza virus comprises the steps of: (1) amplifying the gene encoding nucleocapsid having the nucleotide sequence of SEQ ID NO:1 as a common protein of MS96 strain with PCR, and cloning the PCR amplified gene into the TA cloning vector; (2) re-isolating the NP gene inserted into the TA cloning vector with a restriction enzyme EcoR I, and inserting the isolated NP gene into the baculovirus transition vector pBacPAK8 to prepare the baculovirus transition vector pBacAINP; (3) co-transfecting the Sf21 cell with the baculovirus and the transition vector pBacAINP to a recombinant baculovirus(rAINP) expressing the avian influenza virus NP protein; and (4) verifying the expression of avian influenza virus NP(nucleus protein) in the Sf21 cell by using a monoclonal antibody specific to the avian influenza virus NP.
Abstract translation:提供禽流感病毒的重组蛋白和含有相同蛋白质的禽流感诊断组合物,以便大量生产用于禽流感诊断的抗原,从而防止禽流感引起的疾病。 制备禽流感病毒重组核蛋白的方法包括以下步骤:(1)用PCR扩增编码具有SEQ ID NO:1的核苷酸序列的核衣壳的基因作为MS96菌株的常见蛋白质,并将PCR扩增 基因进入TA克隆载体; (2)用限制酶EcoR I重新分离插入TA克隆载体的NP基因,将分离的NP基因插入杆状病毒转移载体pBacPAK8中以制备杆状病毒转移载体pBacAINP; (3)将杆状病毒和过渡载体pBacAINP的Sf21细胞共转染至表达禽流感病毒NP蛋白的重组杆状病毒(rAINP); 和(4)通过使用特异于禽流感病毒NP的单克隆抗体来验证Sf21细胞中禽流感病毒NP(核蛋白)的表达。
Abstract:
PURPOSE: An antigen for hemoglutination for swine Japanese encephalitis virus is provided to reduce pollution caused by acetone extraction. CONSTITUTION: A method for preparing antigen for hemoglutination of high concentration for swine Japanese encephalitis virus comprises: a step of inoculating swine Japanese encephalitis virus to a tissue culture cells and planting; a step of freezing culture liquid; a step of thawing the culture liquid and repeating freezing and thawing once; a step of collecting cultured swine Japanese encephalitis virus; a step of inactivating swine Japanese encephalitis virus; a step of concentrating swine Japanese encephalitis virus; and a step of precipitating swine Japanese encephalitis virus by centrifugation.
Abstract:
PURPOSE: A probe composition for detecting avian influenza virus is provided to simultaneously test the subtypes of HA gene and NA gene and pathogenicity and to quickly and accurately diagnose avian influenza virus. CONSTITUTION: A probe composition for determining serotype and pathogenicity of avian influenza virus contains: at least one probe selected among oligonucleotides with base sequences of sequence numbers 10-24 and complementary oligonucleotides thereof for determining the subtype of HA gene in avian influenza virus; at least one probe selected among oligonucleotides with base sequences of sequence numbers 27-46 and complementary oligonucleotides thereof for determining high pathogenicity of avian influenza virus; and at least one probe selected among oligonucleotides with base sequences of sequence numbers 47-63 and complementary oligonucleotides thereof for determining low pathogenicity of avian influenza virus.
Abstract:
본 발명은 HA 단백질 분절부위 아미노산 배열의 모티프가 TSGR을 가지며, 국내유행 저병원성 조류인플루엔자 바이러스에 방어능력을 나타내는 백신제조용 H9N2 혈청형의 저병원성 조류인플루엔자 바이러스주를 제공한다. 상기 바이러스주를 백신제조용 원료로 사용하는 경우 양계산업에 있어 산란율 저하 및 폐사 등 지속적인 문제를 일으키는 H9N2 혈청형 저병원성 조류인플루엔자 예방에 활용이 가능하다. 저병원성 조류인플루엔자, H9N2, 백신